Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.250 GBX | 0.00% | -21.28% | -38.33% |
09-17 | Coral Products swings to loss after suffering challenging environment | AN |
09-17 | Coral Products PLC Reports Earnings Results for the Full Year Ended April 30, 2024 | CI |
Fiscal Period: April | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.63 | 0.16 | 1.77 | 5.66 | 5.25 | |||||
Return on Total Capital | 1.95 | 0.21 | 2.2 | 6.7 | 6.75 | |||||
Return On Equity % | 0.64 | -3.05 | -1.93 | 7.91 | 9.85 | |||||
Return on Common Equity | 0.64 | -3.05 | -1.93 | 7.91 | 9.85 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.87 | 33.43 | 35.48 | 36.74 | 29.75 | |||||
SG&A Margin | 33.21 | 32.67 | 29.83 | 25.56 | 23.6 | |||||
EBITDA Margin % | 9.74 | 15.8 | 12.84 | 14.6 | 8.92 | |||||
EBITA Margin % | 3.83 | 3.94 | 8.3 | 13.45 | 7.6 | |||||
EBIT Margin % | 2.66 | 0.76 | 5.65 | 11.18 | 6.14 | |||||
Income From Continuing Operations Margin % | 0.34 | -4.38 | -2.24 | 6.72 | 3.57 | |||||
Net Income Margin % | 0.34 | -9.43 | 4.43 | 6.72 | 3.57 | |||||
Net Avail. For Common Margin % | 0.34 | -4.38 | -2.24 | 6.72 | 3.57 | |||||
Normalized Net Income Margin | 0.56 | -0.44 | 2.88 | 6.63 | 3.03 | |||||
Levered Free Cash Flow Margin | 1.95 | 17.66 | -1.28 | 42.26 | -4.47 | |||||
Unlevered Free Cash Flow Margin | 3.06 | 18.57 | -0.63 | 42.61 | -3.65 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.98 | 0.35 | 0.5 | 0.81 | 1.37 | |||||
Fixed Assets Turnover | 2.64 | 1.05 | 2.31 | 6.74 | 5.76 | |||||
Receivables Turnover (Average Receivables) | 5.22 | 2.08 | 3.41 | 5.49 | 7.82 | |||||
Inventory Turnover (Average Inventory) | 4.98 | 1.69 | 2.66 | 5.05 | 8.11 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.03 | 1.16 | 3.28 | 2.74 | 1.16 | |||||
Quick Ratio | 0.56 | 0.47 | 2.06 | 2.25 | 0.78 | |||||
Operating Cash Flow to Current Liabilities | 0.17 | 0.27 | 0.48 | 0.58 | -0.08 | |||||
Days Sales Outstanding (Average Receivables) | 69.91 | 176.14 | 106.95 | 66.45 | 46.68 | |||||
Days Outstanding Inventory (Average Inventory) | 73.28 | 217.08 | 137.17 | 72.35 | 45.01 | |||||
Average Days Payable Outstanding | 66.54 | 193.61 | 153.87 | 66.76 | 37.22 | |||||
Cash Conversion Cycle (Average Days) | 76.65 | 199.61 | 90.26 | 72.04 | 54.46 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 63.64 | 55.16 | 22.35 | 23.17 | 85.22 | |||||
Total Debt / Total Capital | 38.89 | 35.55 | 18.27 | 18.81 | 46.01 | |||||
LT Debt/Equity | 25.31 | 20.73 | 8.13 | 7.75 | 34.43 | |||||
Long-Term Debt / Total Capital | 15.47 | 13.36 | 6.64 | 6.29 | 18.59 | |||||
Total Liabilities / Total Assets | 49.03 | 50.98 | 28.99 | 33.52 | 59.16 | |||||
EBIT / Interest Expense | 1.5 | 0.52 | 5.45 | 19.62 | 4.72 | |||||
EBITDA / Interest Expense | 5.5 | 16.19 | 18.4 | 29.23 | 8.4 | |||||
(EBITDA - Capex) / Interest Expense | 3.92 | 13.65 | 14.31 | 26.72 | 3.86 | |||||
Total Debt / EBITDA | 3.41 | 3.25 | 1.39 | 1.13 | 3.07 | |||||
Net Debt / EBITDA | 3.41 | 3.03 | -0.49 | -2.03 | 1.83 | |||||
Total Debt / (EBITDA - Capex) | 4.78 | 3.85 | 1.79 | 1.24 | 6.68 | |||||
Net Debt / (EBITDA - Capex) | 4.78 | 3.59 | -0.63 | -2.23 | 3.98 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % |